Literature DB >> 7876548

IL-7 in the cell-mediated immune response to a human pathogen.

P A Sieling1, L Sakimura, K Uyemura, M Yamamura, J Oliveros, B J Nickoloff, T H Rea, R L Modlin.   

Abstract

The goal of the present study was to investigate the role of IL-7 in regulating immune responses to infection. Leprosy provides a model for understanding human immune responses to infection; the disease presents as a spectrum in which the clinical manifestations correlate with the levels of cell-mediated immunity to the pathogen, Mycobacterium leprae. To determine whether IL-7 is produced at the site of infection in leprosy, we used the PCR to measure IL-7 and IL-7R mRNA in skin lesions. IL-7 mRNA was more strongly expressed in the tuberculoid form of the disease, in which the infection is limited (mean cpm = 48 +/- 8; n = 11), as compared with the progressive lepromatous form (17 +/- 2; n = 11). IL-7R mRNA, both membrane-bound and soluble forms, were also more strongly expressed in tuberculoid lesions, although these differences were not as striking as those for IL-7. The cellular source of IL-7 included Ag-stimulated monocytes and IFN-gamma-induced keratinocytes. M. leprae-induced PBMC responses in tuberculoid patients involved up-regulation of IL-7 and IL-7R mRNA and was IL-7 dependent. In contrast, M. leprae did not induce IL-7 mRNA in lepromatous patients, and their T cell responses were weakly augmented by rIL-7. These data suggest that IL-7, produced at the site of disease, contributes to the cell-mediated immune response to human pathogens.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7876548

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Bystander activation of CD8+ T lymphocytes during experimental mycobacterial infection.

Authors:  Brad Gilbertson; Susie Germano; Pauline Steele; Steven Turner; Barbara Fazekas de St Groth; Christina Cheers
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

2.  Prime-boost vaccination with rBCG/rAd35 enhances CD8⁺ cytolytic T-cell responses in lesions from Mycobacterium tuberculosis-infected primates.

Authors:  Sayma Rahman; Isabelle Magalhaes; Jubayer Rahman; Raija K Ahmed; Donata R Sizemore; Charles A Scanga; Frank Weichold; Frank Verreck; Ivanela Kondova; Jerry Sadoff; Rigmor Thorstensson; Mats Spångberg; Mattias Svensson; Jan Andersson; Markus Maeurer; Susanna Brighenti
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

Review 3.  Interleukin-7 induced immunopathology in arthritis.

Authors:  S A Y Hartgring; J W J Bijlsma; F P J G Lafeber; J A G van Roon
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

4.  Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice.

Authors:  M J Maeurer; P Trinder; G Hommel; W Walter; K Freitag; D Atkins; S Störkel
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

5.  Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary report.

Authors:  Mariane M Stefani; Jackeline G Guerra; Ana Lucia M Sousa; Mauricio B Costa; Maria Leide W Oliveira; Celina T Martelli; David M Scollard
Journal:  BMC Infect Dis       Date:  2009-05-27       Impact factor: 3.090

6.  Diminished plasma levels of common γ-chain cytokines in pulmonary tuberculosis and reversal following treatment.

Authors:  Nathella Pavan Kumar; Vaithilingam V Banurekha; Dina Nair; Subash Babu
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

7.  Low Interleukin-7 Receptor Messenger RNA Expression Is Independently Associated With Day 28 Mortality in Septic Shock Patients.

Authors:  Benjamin Delwarde; Estelle Peronnet; Fabienne Venet; Elisabeth Cerrato; Boris Meunier; Julie Mouillaux; Alain Lepape; Alexandre Pachot; Thomas Rimmelé; Guillaume Monneret; Julien Textoris
Journal:  Crit Care Med       Date:  2018-11       Impact factor: 7.598

8.  Genetic variation in interleukin-7 is associated with a reduced erythropoietic response in Kenyan children infected with Plasmodium falciparum.

Authors:  Lily E Kisia; Prakasha Kempaiah; Samuel B Anyona; Elly O Munde; Angela O Achieng; John M Ong'echa; Christophe G Lambert; Kiprotich Chelimo; Collins Ouma; Douglas J Perkins; Evans Raballah
Journal:  BMC Med Genet       Date:  2019-08-16       Impact factor: 2.103

9.  IL-7-Adjuvanted Vaginal Vaccine Elicits Strong Mucosal Immune Responses in Non-Human Primates.

Authors:  Sandrine Logerot; Suzanne Figueiredo-Morgado; Bénédicte Charmeteau-de-Muylder; Abdelkader Sandouk; Anne-Sophie Drillet-Dangeard; Morgane Bomsel; Isabelle Bourgault-Villada; Anne Couëdel-Courteille; Rémi Cheynier; Magali Rancez
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.